No connection

Search Results

ALKS vs LNTH

ALKS
Alkermes plc
BEARISH
Price
$27.76
Market Cap
$4.63B
Sector
Healthcare
AI Confidence
85%
LNTH
Lantheus Holdings, Inc.
NEUTRAL
Price
$80.59
Market Cap
$5.25B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ALKS
19.41
LNTH
23.63
Forward P/E
ALKS
13.4
LNTH
12.81
P/B Ratio
ALKS
2.53
LNTH
4.78
P/S Ratio
ALKS
3.13
LNTH
3.4
EV/EBITDA
ALKS
14.61
LNTH
14.31

Profitability

Gross Margin
ALKS
86.69%
LNTH
61.1%
Operating Margin
ALKS
15.11%
LNTH
19.07%
Profit Margin
ALKS
16.37%
LNTH
15.15%
ROE
ALKS
14.72%
LNTH
21.45%
ROA
ALKS
6.99%
LNTH
9.28%

Growth

Revenue Growth
ALKS
-10.6%
LNTH
4.0%
Earnings Growth
ALKS
-67.0%
LNTH
--

Financial Health

Debt/Equity
ALKS
0.04
LNTH
0.57
Current Ratio
ALKS
3.55
LNTH
2.7
Quick Ratio
ALKS
1.7
LNTH
2.2

Dividends

Dividend Yield
ALKS
--
LNTH
--
Payout Ratio
ALKS
0.0%
LNTH
0.0%

AI Verdict

ALKS BEARISH

ALKS exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, raising concerns about default risk. Despite a strong Graham Number of $18.80 and intrinsic value estimate of $10.01, the current price of $27.76 trades at a significant premium, especially given deteriorating growth and profitability metrics. The company shows a sharp decline in revenue and earnings (YoY: -10.6% and -67.0%), with recent quarterly earnings missing expectations and negative Q/Q trends. Insider selling activity over the past six months further undermines confidence, despite strong historical earnings surprises. The market appears to be pricing in future recovery, but current fundamentals suggest caution.

Strengths
Strong gross margin of 86.69% indicates high product pricing power and cost control
Exceptionally low debt/equity ratio of 0.04 reflects conservative capital structure and strong financial stability
High current ratio (3.55) and quick ratio (1.70) signal robust short-term liquidity
Risks
Piotroski F-Score of 4/9 indicates weak financial health, with only marginal stability
Significant year-over-year earnings and revenue decline (-67.0% and -10.6%) suggest deteriorating business momentum
Recent insider selling activity (4 transactions, $0.77M value) signals potential internal skepticism
LNTH NEUTRAL

LNTH exhibits strong operational health with a Piotroski F-Score of 7/9 and robust liquidity (Current Ratio 2.70), though it lacks an Altman Z-Score for bankruptcy benchmarking. While the company is highly profitable with an ROE of 21.45% and a consistent track record of earnings beats, the stock trades at a significant premium to its Graham Number ($35.98) and Intrinsic Value ($23.87). The bullish outlook is supported by a low Forward P/E of 12.81 and a positive analyst target of $91.38, but the current price is disconnected from deterministic value metrics.

Strengths
Strong financial health indicated by a Piotroski F-Score of 7/9
Excellent liquidity with a Current Ratio of 2.70 and Quick Ratio of 2.20
High profitability with 21.45% ROE and 61.10% Gross Margin
Risks
Significant valuation gap between current price ($80.59) and Graham Number ($35.98)
Modest year-over-year revenue growth of only 4.00%
Bearish technical trend (0/100) despite recent 6-month recovery

Compare Another Pair

ALKS vs LNTH: Head-to-Head Comparison

This page compares Alkermes plc (ALKS) and Lantheus Holdings, Inc. (LNTH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile